RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study

Romain Cohen; Jaafar Bennouna; Aurélia Meurisse; Christophe Tournigand; Christelle De La Fouchardière; David Tougeron; Christophe Borg; Thibault Mazard; Benoist Chibaudel; Marie-Line Garcia-Larnicol; Magali Svrcek; Dewi Vernerey; Yves Menu; Thierry André

doi:10.1136/jitc-2020-001499

Article metrics

PDF

PDF +
Supplementary
Material

XML

Clinical/translational cancer immunotherapy

Original research

RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study

Online download statistics by month:

Online download statistics by month: November 2020 to August 2023

	Abstract	Full	Pdf
Nov 2020	378	380	191
Dec 2020	223	223	95
Jan 2021	111	111	48
Feb 2021	107	107	39
Mar 2021	189	189	57
Apr 2021	91	91	46
May 2021	94	94	38
Jun 2021	78	78	43
Jul 2021	84	84	41
Aug 2021	69	69	38
Sep 2021	79	79	52
Oct 2021	83	83	67
Nov 2021	110	113	97
Dec 2021	80	84	54
Jan 2022	70	73	40
Feb 2022	77	78	42
Mar 2022	140	142	64
Apr 2022	119	123	47
May 2022	83	87	51
Jun 2022	89	102	43
Jul 2022	65	67	36
Aug 2022	67	68	37
Sep 2022	67	67	36
Oct 2022	90	95	69
Nov 2022	82	84	49
Dec 2022	72	72	37
Jan 2023	41	41	34
Feb 2023	114	114	45
Mar 2023	63	64	45
Apr 2023	45	45	33
May 2023	46	46	35
Jun 2023	45	47	32
Jul 2023	35	35	33
Aug 2023	60	61	20
Total	3246	3296	1734

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month: November 2020 to August 2023

Read the full text or download the PDF:

Log in using your username and password